Phase II Clinical Trial of Multiple Peptide Vaccination for Advanced Head and Neck Cancer Patients Revealed Induction of Immune Responses and Improved OS-Reference-Cited by-同舟云学术

Phase II Clinical Trial of Multiple Peptide Vaccination for Advanced Head and Neck Cancer Patients Revealed Induction of Immune Responses and Improved OS

Published:2014-11-12 Issue:2 Volume:21 Page:312-321
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:Clin Cancer Res

Author:

Yoshitake Yoshihiro,Fukuma Daiki,Yuno Akira,Hirayama Masatoshi,Nakayama Hideki,Tanaka Takuya,Nagata Masashi,Takamune Yasuo,Kawahara Kenta,Nakagawa Yoshihiro,Yoshida Ryoji,Hirosue Akiyuki,Ogi Hidenao,Hiraki Akimitsu,Jono Hirofumi,Hamada Akinobu,Yoshida Koji,Nishimura Yasuharu,Nakamura Yusuke,Shinohara Masanori

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 129 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of cell division cycle-associated proteins in regulating cell cycle and promoting tumor progression;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2024-09

2. Targeting NUF2 suppresses gastric cancer progression through G2/M phase arrest and apoptosis induction;Chinese Medical Journal;2024-08-28

3. Multi-omics analysis of overexpressed tumor-associated proteins: gene expression, immunopeptide presentation, and antibody response in oropharyngeal squamous cell carcinoma, with a focus on cancer-testis antigens;Frontiers in Immunology;2024-07-29

4. A phase 3, randomized, double-blind, multicenter, placebo-controlled study of S-588410, a five-peptide cancer vaccine as an adjuvant therapy after curative resection in patients with esophageal squamous cell carcinoma;Esophagus;2024-07-11

5. Immunotherapy: The Fourth Domain in Oral Cancer Therapeutics;Indian Journal of Otolaryngology and Head & Neck Surgery;2024-03-10